Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Jan 30 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              199.90              215.80           261.50    
                   (-7.4 pct)          (-0.3 pct)       (-6.6 pct)  
  Operating           28.12               28.56            33.00    
                   (-1.5 pct)          (+7.5 pct)       (-10.8 pct) 
  Recurring           36.16               33.38            42.50    
                   (+8.3 pct)          (+6.4 pct)       (+0.9 pct)  
  Net                 51.40               26.46            52.50    
                   (+94.2 pct)         (+11.8 pct)      (+65.7 pct) 
  EPS              643.93 yen          331.19 yen       657.75 yen  
  EPS Diluted      643.33 yen          330.92 yen                   
  Ann Div                              110.00 yen       110.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               60.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news